Angiomyolipoma of the Kidney

An angiomyolipoma (an-jee-oh-my-oh-lih-POH-muh) of the kidney is a noncancerous (benign) tumor made of fat, smooth muscle, and blood vessels. These growths are often found by chance during imaging tests for other conditions. While many are small and cause no problems, larger ones can lead to symptoms like pain or bleeding, requiring medical attention.

What is Angiomyolipoma of the Kidney?

An angiomyolipoma (AML) of the kidney is a noncancerous (benign) growth that forms in the kidney. It is made up of three main types of tissue: fat, smooth muscle, and blood vessels. Most AMLs are small and do not cause any symptoms, often discovered incidentally during medical imaging for other reasons.

Angiomyolipomas are considered benign, meaning they are not cancerous and do not spread to other parts of the body. They are the most common benign kidney tumor. These tumors can vary greatly in size, from just a few millimeters to several centimeters. Most angiomyolipomas occur in only one kidney and are solitary, meaning there is only one tumor. These are called sporadic AMLs. In some cases, people can develop multiple AMLs, often in both kidneys, which is usually linked to a genetic condition called tuberous sclerosis complex (TSC). While AMLs are generally harmless, larger tumors, especially those over about 4 centimeters (1.6 inches) in size, carry a higher risk of complications. These complications can include bleeding into the tumor or surrounding kidney tissue, which can be serious.

Symptoms

Many angiomyolipomas, especially smaller ones, do not cause any noticeable symptoms and are often discovered by chance. When symptoms do occur, they are usually related to the tumor's size or if it starts to bleed. These symptoms can range from mild discomfort to severe pain.

If an angiomyolipoma grows large enough or bleeds, you might experience several symptoms. The most common symptom is pain in your side or back (flank pain). This pain can be dull and persistent or, if there's bleeding, sudden and severe. Other possible symptoms include blood in your urine (hematuria), which may make your urine appear pink, red, or cola-colored. Some people may also develop high blood pressure (hypertension) or feel a lump in their abdomen. In rare cases, a large AML can affect kidney function. Internal bleeding from an AML can be a serious medical emergency. If a tumor ruptures and bleeds significantly, it can cause sudden, intense pain, a rapid heart rate, dizziness, and even shock. These symptoms require immediate medical attention.

Causes & risk factors

The exact cause of most angiomyolipomas is not fully understood, and they often appear without a clear reason, known as sporadic cases. However, there is a strong link between developing multiple angiomyolipomas and a specific genetic disorder called tuberous sclerosis complex (TSC).

Most angiomyolipomas are sporadic, meaning they develop randomly in people who do not have any known genetic conditions. These sporadic AMLs typically occur as a single tumor in one kidney and are more common in women, usually appearing in middle age. The most significant risk factor for developing angiomyolipomas is tuberous sclerosis complex (TSC). This is a rare genetic disorder that causes noncancerous tumors to grow in various organs, including the brain, skin, heart, lungs, and kidneys. About 80% of people with TSC will develop angiomyolipomas, often multiple tumors in both kidneys. While TSC is a genetic condition, sporadic AMLs do not typically run in families. Researchers continue to study the cellular pathways involved in AML development, particularly the mTOR pathway, which is often overactive in both sporadic and TSC-related cases.

How it's diagnosed

Angiomyolipomas are usually diagnosed through imaging tests, which can clearly show the characteristic fat content within the tumor. These tests are often performed for other reasons, leading to the incidental discovery of the AML.

The primary methods for diagnosing an angiomyolipoma involve medical imaging. An ultrasound is often the first test, as it can detect masses in the kidney. However, more detailed imaging is usually needed for a definitive diagnosis. Computed tomography (CT) scans and magnetic resonance imaging (MRI) are highly effective in diagnosing AMLs. These scans can clearly identify the fat component within the tumor, which is a key feature distinguishing AMLs from other kidney masses, including cancerous ones. The presence of fat helps doctors confidently diagnose an AML without needing a biopsy in most cases. In situations where the imaging results are not clear, or if the tumor does not contain a significant amount of fat, a kidney biopsy might be performed. During a biopsy, a small tissue sample is removed and examined under a microscope to confirm the diagnosis and rule out other conditions.

Treatment options

Treatment for an angiomyolipoma depends on its size, whether it's causing symptoms, and if it's growing. Small, asymptomatic tumors are often monitored with regular imaging, while larger or symptomatic ones may require intervention to prevent complications like bleeding.

For small angiomyolipomas (typically less than 4 centimeters or 1.6 inches) that are not causing any symptoms, a "watchful waiting" approach is often recommended. This involves regular follow-up imaging tests, such as ultrasound or CT scans, to monitor the tumor's size and growth over time. If the tumor remains stable and asymptomatic, no active treatment may be needed. If an AML is large, growing rapidly, or causing symptoms like pain or bleeding, treatment options become necessary. One common procedure is arterial embolization. This involves injecting a substance into the blood vessels supplying the tumor to block blood flow, which can stop bleeding and shrink the tumor. This is often used for actively bleeding AMLs. Surgery may be recommended for very large tumors, those that continue to grow despite other treatments, or if there's a concern about cancer. Whenever possible, surgeons aim for a partial nephrectomy, which removes only the tumor while preserving as much healthy kidney tissue as possible. In some cases, if the tumor is very large or has caused significant damage, a total nephrectomy (removal of the entire kidney) might be necessary. For angiomyolipomas associated with tuberous sclerosis complex (TSC), certain medications called mTOR inhibitors (like everolimus) can help shrink the tumors and reduce the risk of bleeding.

Recovery & outlook

The outlook for people with angiomyolipoma is generally very good, especially for those with small, sporadic tumors. Most people recover well after treatment, and many never require intervention. Regular monitoring is key to managing the condition and preventing complications.

For individuals with small, sporadic angiomyolipomas that are managed with watchful waiting, the outlook is excellent. These tumors often remain stable for many years and may never cause problems or require treatment. Regular follow-up appointments and imaging are important to ensure the tumor does not grow or develop complications. If treatment like embolization or partial nephrectomy is needed, recovery typically involves a period of rest and pain management. Most people recover fully and can return to their normal activities. The goal of treatment is to resolve symptoms and prevent future bleeding while preserving kidney function. For those with angiomyolipomas related to tuberous sclerosis complex (TSC), the condition requires lifelong management. While treatments like mTOR inhibitors can help control tumor growth, ongoing monitoring and care are essential due to the potential for multiple tumors and involvement of other organs. Overall, with appropriate medical care, most people with angiomyolipoma can maintain a good quality of life.

When to see a doctor

You should see a doctor if you experience new or worsening symptoms that could be related to an angiomyolipoma. Immediate medical attention is crucial for signs of severe bleeding, as this can be a life-threatening emergency.

If you have been diagnosed with an angiomyolipoma, it's important to follow your doctor's recommendations for monitoring. You should contact your doctor if you develop any new symptoms, such as persistent flank or back pain, or if you notice blood in your urine. Seek immediate medical care or go to the nearest emergency room if you experience sudden, severe pain in your side or back. This could indicate a ruptured angiomyolipoma with internal bleeding. Other emergency signs include feeling dizzy or lightheaded, having a rapid heart rate, or experiencing extreme weakness, as these can be signs of significant blood loss and shock.

Frequently asked questions

Is an angiomyolipoma a type of cancer?

No, an angiomyolipoma is a noncancerous (benign) tumor. It does not spread to other parts of the body like cancer does. However, it can sometimes grow large enough to cause problems or bleeding.

How fast do angiomyolipomas usually grow?

The growth rate of angiomyolipomas can vary. Many remain stable for years, while others may grow slowly. Rapid growth is less common but can increase the risk of symptoms or complications like bleeding.

Can diet or lifestyle changes prevent angiomyolipomas?

There is no evidence that specific diet or lifestyle changes can prevent the development of angiomyolipomas. Most cases are sporadic, or linked to a genetic condition (tuberous sclerosis complex) that is not influenced by diet.

Do I need surgery if I have an angiomyolipoma?

Not always. Small, asymptomatic angiomyolipomas are often managed with watchful waiting and regular monitoring. Surgery or other interventions are typically reserved for larger tumors, those causing symptoms, or if there's a risk of bleeding.

Can an angiomyolipoma affect my kidney function?

Usually, small angiomyolipomas do not affect kidney function. However, very large tumors, or those that cause significant bleeding or require extensive surgery, can potentially impact kidney function. Regular monitoring helps assess this risk.

What is the risk of an angiomyolipoma bleeding?

The risk of bleeding increases with the size of the angiomyolipoma, especially for tumors larger than about 4 centimeters (1.6 inches). Bleeding can range from minor to severe, requiring urgent medical attention.

Sources

• MedlinePlus — Angiomyolipoma of the Kidney
• Mayo Clinic — Angiomyolipoma of the Kidney
• Cochrane Library — Angiomyolipoma of the Kidney